EG24138A - Asymmetrics synthesis of pregabalin - Google Patents

Asymmetrics synthesis of pregabalin

Info

Publication number: EG24138A
Authority: EG; Egypt
Prior art keywords: asymmetrics; pregabalin; synthesis; asymmetrics synthesis
Prior art date: 2000-01-27

Application number

EG20010073A

Other languages

English (en)

Inventor

Burk Mark

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-27

Filing date

2001-01-24

Publication date

2008-08-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26874236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG24138(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-01-24 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2008-08-06 Application granted granted Critical

2008-08-06 Publication of EG24138A publication Critical patent/EG24138A/xx

Links

230000015572 biosynthetic process Effects 0.000 title 1
AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 title 1
229960001233 pregabalin Drugs 0.000 title 1
238000003786 synthesis reaction Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Catalysts (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EG20010073A 2000-01-27 2001-01-24 Asymmetrics synthesis of pregabalin EG24138A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17835900P	2000-01-27	2000-01-27
US19042700P	2000-03-17	2000-03-17

Publications (1)

Publication Number	Publication Date
EG24138A true EG24138A (en)	2008-08-06

Family

ID=26874236

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG20010073A EG24138A (en)	2000-01-27	2001-01-24	Asymmetrics synthesis of pregabalin

Country Status (50)

Country	Link
US (1)	US6891059B2 (fr)
EP (1)	EP1250311B1 (fr)
JP (2)	JP4235384B2 (fr)
KR (1)	KR100549748B1 (fr)
CN (1)	CN1210253C (fr)
AP (1)	AP1438A (fr)
AR (1)	AR028499A1 (fr)
AT (1)	ATE261930T1 (fr)
AU (1)	AU777046B2 (fr)
BG (1)	BG65560B1 (fr)
BR (1)	BRPI0107863B8 (fr)
CA (1)	CA2396090C (fr)
CO (1)	CO5251411A1 (fr)
CR (1)	CR6703A (fr)
CU (1)	CU23221A3 (fr)
CY (1)	CY2004011I1 (fr)
CZ (1)	CZ302838B6 (fr)
DE (1)	DE60102356T2 (fr)
DK (1)	DK1250311T3 (fr)
DZ (1)	DZ3268A1 (fr)
EA (1)	EA004934B1 (fr)
EE (1)	EE05216B1 (fr)
EG (1)	EG24138A (fr)
ES (1)	ES2219493T3 (fr)
GE (1)	GEP20043236B (fr)
HN (1)	HN2001000010A (fr)
HR (1)	HRP20020627B1 (fr)
HU (1)	HU228815B1 (fr)
IL (2)	IL150633A0 (fr)
IS (1)	IS2038B (fr)
MA (1)	MA26869A1 (fr)
ME (1)	ME00921B (fr)
MX (1)	MXPA02007307A (fr)
MY (1)	MY127152A (fr)
NO (1)	NO327958B1 (fr)
NZ (1)	NZ519551A (fr)
OA (1)	OA12167A (fr)
PA (1)	PA8510501A1 (fr)
PE (1)	PE20011063A1 (fr)
PL (1)	PL203985B1 (fr)
PT (1)	PT1250311E (fr)
RS (1)	RS50257B (fr)
SI (1)	SI1250311T1 (fr)
SK (1)	SK287303B6 (fr)
SV (1)	SV2002000295A (fr)
TN (1)	TNSN01016A1 (fr)
TR (1)	TR200400953T4 (fr)
TW (1)	TWI288128B (fr)
UA (1)	UA75584C2 (fr)
WO (1)	WO2001055090A1 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0934061B3 (fr)	1996-07-24	2015-01-21	Warner-Lambert Company LLC	Isobutylgaba et ses derives utilises pour le traitement de la douleur
TR200400953T4 (tr) *	2000-01-27	2004-07-21	Warner Lambert Company	Pregabalinin asimetrik sentezi.
US6687187B2 (en) *	2000-08-11	2004-02-03	Phonak Ag	Method for directional location and locating system
EP1543831A1 (fr) *	2003-12-18	2005-06-22	Pfizer GmbH Arzneimittelwerk Gödecke	Composition de pregabaline
PT1727620E (pt) *	2004-03-12	2007-11-05	Warner Lambert Co	Ligandos de biofosfina c1-simétricos e a sua utilização na síntese assimétrica da pregabalina
UA82292C2 (uk) *	2004-04-14	2008-03-25	Пфайзер Продактс Инк.	Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
CN1972904B (zh) *	2004-06-21	2011-02-02	沃尼尔·朗伯有限责任公司	普瑞巴林和相关化合物的制备
CN101160281A (zh) *	2005-04-06	2008-04-09	特瓦制药工业有限公司	结晶形态的普瑞巴林
US7488846B2 (en) *	2005-04-11	2009-02-10	Teva Pharmaceuical Industries Ltd.	Pregabalin free of lactam and a process for preparation thereof
MX2007012606A (es) *	2005-04-11	2008-01-11	Teva Pharma	Proceso para elaborar (s)-pregabalina.
MX2007000525A (es) *	2005-05-10	2007-03-28	Teva Pharma	Pregabalina libre de acido isobutilglutarico y un proceso para la preparacion de ella.
WO2006122258A1 (fr)	2005-05-10	2006-11-16	Teva Pharmaceutical Industries Ltd.	Procede pour preparer de la pregabaline et des sels de celle-ci
ES2372700T3 (es)	2005-05-10	2012-01-25	Teva Pharmaceutical Industries Ltd	Resolución óptica del ácido 3-carbamoilmetil-5-metil hexanoico.
US20060270871A1 (en) *	2005-05-30	2006-11-30	Khanduri Chandra H	Polymorphic form i of pregabalin and processes for its preparation
CN100410242C (zh) *	2005-06-23	2008-08-13	江苏恩华药业股份有限公司	普瑞巴林中间体及其制备方法
WO2007035789A1 (fr)	2005-09-19	2007-03-29	Teva Pharmaceutical Industries Ltd.	Acides 3-carbamoylméthyl-5-méthylhexanoïques chiraux, intermédiaires clés pour la nouvelle synthèse de la (s)-prégabaline
NL2000281C2 (nl) *	2005-11-02	2007-08-07	Pfizer Prod Inc	Vaste farmaceutische samenstellingen die pregabaline bevatten.
WO2007127309A2 (fr) *	2006-04-24	2007-11-08	Teva Pharmaceutical Industries Ltd.	Procede de synthese d'acide 3-isobutylglutarique
WO2007139933A2 (fr)	2006-05-24	2007-12-06	Teva Pharmaceutical Industries Ltd.	Procédés pour la préparation d'acide r-(+)-3-(carbamoyl méthyl)-5-méthylhexanoïque et de sels de celui-ci
WO2007143113A2 (fr) *	2006-05-31	2007-12-13	Teva Pharmaceutical Industries Ltd.	Utilisation de la résolution enzymatique pour la préparation d'intermédiaires de prégabaline
WO2007143152A2 (fr) *	2006-05-31	2007-12-13	Teva Pharmaceutical Industries Ltd.	Préparation de (s)-prégabaline nitrile
EP1903027A1 (fr) *	2006-09-13	2008-03-26	Novartis AG	Procédé de préparation de l' acide amino-4 butyrique ou de ses derivés et leur utilisation pour la préparation des inhibiteurs NEP
TW200846308A (en)	2007-03-22	2008-12-01	Teva Pharma	Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid
US8168828B2 (en)	2007-06-25	2012-05-01	Msn Laboratories, Limited	Process for the preparation of pregabalin
KR100846419B1 (ko) *	2007-08-10	2008-07-15	한국과학기술원	프레가발린의 신규한 제조 방법
WO2009046309A2 (fr) *	2007-10-03	2009-04-09	Teva Pharmaceutical Industries Ltd.	Prégabaline-4-éliminée, prégabaline-5-éliminée, leur utilisation en tant que marqueur de référence et standard et procédé de production de prégabaline contenant de faibles taux de ceux-ci
EP2053040A1 (fr) *	2007-10-26	2009-04-29	Chemo Ibérica, S.A.	Intermédiaires de la Prégabaline et leurs procédés de préparation et Prégabaline
EP2225199A2 (fr) *	2007-12-18	2010-09-08	Watson Pharma Private Limited	Procédé perfectionné pour la préparation de (s)-prégabaline
EP2222630A1 (fr) *	2007-12-26	2010-09-01	Generics (UK) Limited	Procédés de préparation de la prégabaline
AU2008345851B2 (en) *	2008-01-10	2012-08-16	Sumitomo Chemical Company, Limited	Method for producing cyclopropane carboxylic acid compound and intermediate therefor
EP2110372A1 (fr)	2008-04-16	2009-10-21	Chemo Ibérica, S.A.	Intermédiaires pour la préparation de prégabaline et leur procédé de préparation
SG157299A1 (en)	2008-05-09	2009-12-29	Agency Science Tech & Res	Diagnosis and treatment of kawasaki disease
SI2294207T1 (sl)	2008-05-21	2013-01-31	Sandoz Ag	Postopek za stereoselektivno encimatsko hidrolizo estra 5-metil-3-nitrometil-heksanojske kisline
WO2009158343A1 (fr) *	2008-06-23	2009-12-30	Teva Pharmaceutical Industries, Ltd.	Synthèse enzymatique stéréosélective de l’ester (s) ou (r)-isobutylglutarique
WO2010070593A2 (fr)	2008-12-19	2010-06-24	Pfizer Ireland Pharmaceuticals	Esters de malonate
CN101987826A (zh) *	2009-08-04	2011-03-23	铜陵凯顺生物科技有限公司	一种(3s)-3-氨甲基-5-甲基己酸的合成方法
WO2011141923A2 (fr)	2010-05-14	2011-11-17	Lupin Limited	Synthèse améliorée d'un ester alkylique optiquement pur de l'acide (s) - 3-cyano-5-méthyl-hexanoïque, intermédiaire de la (s)-prégabaline
US8212072B2 (en)	2010-08-13	2012-07-03	Divi's Laboratories, Ltd.	Process for the preparation of pregabalin
WO2012025861A1 (fr) *	2010-08-23	2012-03-01	Pfizer Manufacturing Ireland	Procédé de préparation de dérivés d'acide (s)-3-cyano-5-méthylhexanoïque et de prégabaline
CN102464594B (zh) *	2010-11-17	2014-06-25	凯瑞斯德生化(苏州)有限公司	普瑞巴林的中间体化合物的制备方法
US9422230B2 (en)	2013-05-09	2016-08-23	Council Of Scientific And Industrial Research	Process for the preparation of an anticonvulsant agent pregabalin hydrochloride
WO2016075082A1 (fr)	2014-11-10	2016-05-19	Sandoz Ag	Amination réductrice stéréosélective d'aldéhydes alpha-chiraux au moyen d'ω-transaminases pour la synthèse de précurseurs de la prégabaline et du brivaracétam
WO2017019791A1 (fr)	2015-07-27	2017-02-02	Teva Pharmaceuticals International Gmbh	Synthèse de (s)-prégabaline

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS588390B2 (ja) *	1978-05-23	1983-02-15	住友化学工業株式会社	光学活性ω↓−シアノ↓−α↓−アシルアミノ酸誘導体の製造法
US4939288A (en) *	1989-01-23	1990-07-03	Monsanto Company	Method of preparing (R)-succinic acid derivatives
US6197819B1 (en) *	1990-11-27	2001-03-06	Northwestern University	Gamma amino butyric acid analogs and optical isomers
US5171892A (en) *	1991-07-02	1992-12-15	E. I. Du Pont De Nemours And Company	Chiral phospholanes via chiral 1,4-diol cyclic sulfates
US5616793A (en) *	1995-06-02	1997-04-01	Warner-Lambert Company	Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5637767A (en) *	1995-06-07	1997-06-10	Warner-Lambert Company	Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5840965A (en) *	1996-06-24	1998-11-24	E. I. Du Pont De Nemours And Company	Process for the production of purified telephthalic acid
EP0934061B3 (fr) *	1996-07-24	2015-01-21	Warner-Lambert Company LLC	Isobutylgaba et ses derives utilises pour le traitement de la douleur
US6127418A (en) *	1997-08-20	2000-10-03	Warner-Lambert Company	GABA analogs to prevent and treat gastrointestinal damage
EP1042270B1 (fr)	1997-12-17	2003-04-09	Chirotech Technology Limited	Hydrogenation asymetrique
WO1999052852A1 (fr)	1998-04-09	1999-10-21	Chirotech Technology Limited	Hydrogenation asymetrique
TR200400953T4 (tr) *	2000-01-27	2004-07-21	Warner Lambert Company	Pregabalinin asimetrik sentezi.

2001
- 2001-01-11 TR TR2004/00953T patent/TR200400953T4/xx unknown
- 2001-01-11 EP EP01900035A patent/EP1250311B1/fr not_active Expired - Lifetime
- 2001-01-11 CN CNB018041701A patent/CN1210253C/zh not_active Expired - Fee Related
- 2001-01-11 ME MEP-2008-447A patent/ME00921B/me unknown
- 2001-01-11 HU HU0204307A patent/HU228815B1/hu not_active IP Right Cessation
- 2001-01-11 EE EEP200200403A patent/EE05216B1/xx not_active IP Right Cessation
- 2001-01-11 CA CA002396090A patent/CA2396090C/fr not_active Expired - Fee Related
- 2001-01-11 OA OA1200200227A patent/OA12167A/en unknown
- 2001-01-11 IL IL15063301A patent/IL150633A0/xx unknown
- 2001-01-11 DE DE60102356T patent/DE60102356T2/de not_active Expired - Lifetime
- 2001-01-11 PT PT01900035T patent/PT1250311E/pt unknown
- 2001-01-11 CZ CZ20022520A patent/CZ302838B6/cs not_active IP Right Cessation
- 2001-01-11 GE GEAP20016551A patent/GEP20043236B/en unknown
- 2001-01-11 NZ NZ519551A patent/NZ519551A/en not_active IP Right Cessation
- 2001-01-11 SI SI200130109T patent/SI1250311T1/xx unknown
- 2001-01-11 PL PL357077A patent/PL203985B1/pl unknown
- 2001-01-11 MX MXPA02007307A patent/MXPA02007307A/es active IP Right Grant
- 2001-01-11 AU AU22138/01A patent/AU777046B2/en not_active Ceased
- 2001-01-11 KR KR1020027009629A patent/KR100549748B1/ko not_active Expired - Fee Related
- 2001-01-11 HR HR20020627A patent/HRP20020627B1/xx not_active IP Right Cessation
- 2001-01-11 EA EA200200642A patent/EA004934B1/ru not_active IP Right Cessation
- 2001-01-11 ES ES01900035T patent/ES2219493T3/es not_active Expired - Lifetime
- 2001-01-11 US US10/182,656 patent/US6891059B2/en not_active Expired - Lifetime
- 2001-01-11 AT AT01900035T patent/ATE261930T1/de active
- 2001-01-11 AP APAP/P/2002/002588A patent/AP1438A/en active
- 2001-01-11 DZ DZ013268A patent/DZ3268A1/fr active
- 2001-01-11 WO PCT/IB2001/000024 patent/WO2001055090A1/fr not_active Ceased
- 2001-01-11 SK SK1078-2002A patent/SK287303B6/sk not_active IP Right Cessation
- 2001-01-11 BR BRPI0107863A patent/BRPI0107863B8/pt not_active IP Right Cessation
- 2001-01-11 RS YU56202A patent/RS50257B/sr unknown
- 2001-01-11 JP JP2001555033A patent/JP4235384B2/ja not_active Expired - Fee Related
- 2001-01-11 DK DK01900035T patent/DK1250311T3/da active
- 2001-01-19 TW TW090101221A patent/TWI288128B/zh not_active IP Right Cessation
- 2001-01-23 MY MYPI20010329A patent/MY127152A/en unknown
- 2001-01-23 PA PA20018510501A patent/PA8510501A1/es unknown
- 2001-01-24 HN HN2001000010A patent/HN2001000010A/es unknown
- 2001-01-24 EG EG20010073A patent/EG24138A/xx active
- 2001-01-24 PE PE2001000078A patent/PE20011063A1/es not_active Application Discontinuation
- 2001-01-24 CO CO01005266A patent/CO5251411A1/es active IP Right Grant
- 2001-01-25 AR ARP010100316A patent/AR028499A1/es not_active Application Discontinuation
- 2001-01-26 SV SV2001000295A patent/SV2002000295A/es active IP Right Grant
- 2001-01-26 TN TNTNSN01016A patent/TNSN01016A1/fr unknown
- 2001-11-01 UA UA2002065143A patent/UA75584C2/uk unknown
2002
- 2002-06-19 IS IS6430A patent/IS2038B/is unknown
- 2002-06-19 CU CU20020122A patent/CU23221A3/es unknown
- 2002-06-20 BG BG106849A patent/BG65560B1/bg unknown
- 2002-07-08 IL IL150633A patent/IL150633A/en not_active IP Right Cessation
- 2002-07-16 CR CR6703A patent/CR6703A/es unknown
- 2002-07-23 MA MA26738A patent/MA26869A1/fr unknown
- 2002-07-26 NO NO20023582A patent/NO327958B1/no not_active IP Right Cessation
2004
- 2004-12-20 CY CY2004011C patent/CY2004011I1/el unknown
2008
- 2008-09-30 JP JP2008254068A patent/JP4886753B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO20023582D0 (no)	2002-07-26
BR0107863A (pt)	2002-11-05
IL150633A (en)	2009-08-03
NO20023582L (no)	2002-09-02
JP4886753B2 (ja)	2012-02-29
SK287303B6 (sk)	2010-06-07
CR6703A (es)	2003-06-24
CZ20022520A3 (cs)	2002-10-16
HU228815B1 (en)	2013-05-28
HRP20020627B1 (hr)	2011-01-31
EE200200403A (et)	2003-10-15
CZ302838B6 (cs)	2011-12-07
HUP0204307A2 (hu)	2003-06-28
YU56202A (sh)	2006-01-16
BR0107863B1 (pt)	2013-06-18
IS6430A (is)	2002-06-19
ES2219493T3 (es)	2004-12-01
CU23221A3 (es)	2007-07-20
AP2002002588A0 (en)	2002-09-30
US6891059B2 (en)	2005-05-10
CY2004011I1 (el)	2010-07-28
EA200200642A1 (ru)	2002-12-26
SV2002000295A (es)	2002-06-07
TWI288128B (en)	2007-10-11
AR028499A1 (es)	2003-05-14
DE60102356D1 (de)	2004-04-22
WO2001055090A1 (fr)	2001-08-02
RS50257B (sr)	2009-07-15
CO5251411A1 (es)	2003-02-28
MA26869A1 (fr)	2004-12-20
NZ519551A (en)	2004-02-27
US20030212290A1 (en)	2003-11-13
JP2003520841A (ja)	2003-07-08
MY127152A (en)	2006-11-30
SK10782002A3 (sk)	2002-11-06
PA8510501A1 (es)	2002-02-21
PE20011063A1 (es)	2001-10-18
JP4235384B2 (ja)	2009-03-11
TNSN01016A1 (fr)	2005-11-10
EP1250311B1 (fr)	2004-03-17
IL150633A0 (en)	2003-02-12
CN1396905A (zh)	2003-02-12
KR100549748B1 (ko)	2006-02-08
BG106849A (en)	2003-03-31
OA12167A (en)	2006-05-08
HN2001000010A (es)	2001-06-13
AP1438A (en)	2005-05-23
CA2396090A1 (fr)	2001-08-02
PT1250311E (pt)	2004-07-30
EA004934B1 (ru)	2004-10-28
EE05216B1 (et)	2009-10-15
SI1250311T1 (en)	2004-10-31
UA75584C2 (uk)	2006-05-15
TR200400953T4 (tr)	2004-07-21
HUP0204307A3 (en)	2003-07-28
IS2038B (is)	2005-08-15
ME00921B (me)	2012-06-20
KR20020073187A (ko)	2002-09-19
MXPA02007307A (es)	2002-11-29
DZ3268A1 (fr)	2001-08-02
NO327958B1 (no)	2009-10-26
JP2009073841A (ja)	2009-04-09
CA2396090C (fr)	2006-01-10
AU777046B2 (en)	2004-09-30
AU2213801A (en)	2001-08-07
DK1250311T3 (da)	2004-08-16
HRP20020627A2 (en)	2004-08-31
BG65560B1 (bg)	2008-12-30
CN1210253C (zh)	2005-07-13
DE60102356T2 (de)	2005-02-17
EP1250311A1 (fr)	2002-10-23
PL357077A1 (en)	2004-07-12
ATE261930T1 (de)	2004-04-15
PL203985B1 (pl)	2009-11-30
BRPI0107863B8 (pt)	2017-04-25
GEP20043236B (en)	2004-05-25

Publication	Publication Date	Title
IL150633A0 (en)	2003-02-12	Asymmetric synthesis of pregabalin
AU146016S (en)	2001-11-30	Wristwatch
AU3467101A (en)	2001-08-07	Mucin synthesis inhibitors
GB0013241D0 (en)	2000-07-19	Voice synthesis
GB0100628D0 (en)	2001-02-21	Synthesis of tetramethylammonium hydroxide
MXPA03000914A (es)	2003-10-06	Sintesis de (r)-3-(4 -bromobencil) -1-(3, 5-diclorofenil) -5-yodo-3 -metil-1-h -imidazo[1, 2-a]imidazol -2-ona.
TW444674U (en)	2001-07-01	Improved structure of ornament
AU2132002A (en)	2002-06-18	Synthesis of small particles
GB0014876D0 (en)	2000-08-09	Chemical synthesis
IL161608A0 (en)	2004-09-27	Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
GB0002333D0 (en)	2000-03-22	Compound synthesis
GB0004699D0 (en)	2000-04-19	Chemical synthesis
GC0000267A (en)	2006-11-01	Asymmetric synthesis of pregabalin
GB0320310D0 (en)	2003-10-01	Bracelet
GB0225106D0 (en)	2002-12-11	Synthesis of 3 hydroxy-5 -steroids
AU143517S (en)	2001-04-10	Wristwatch
AU2001259381A1 (en)	2001-12-11	Synthesis of diphosphinoarenes
AU6715501A (en)	2002-01-08	Synthesis of cyclic compounds
GB0030689D0 (en)	2001-01-31	Synthesis
GB0017055D0 (en)	2000-08-30	Synthesis
GB0015568D0 (en)	2000-08-16	Ester synthesis
GB0017074D0 (en)	2000-08-30	Ester synthesis
GB9800464D0 (en)	1998-03-04	Efficient synthesis of cycloproplacetylene
AU2002357226A8 (en)	2003-06-30	The total synthesis of merrilactone a
CA89847S (en)	2000-06-30	Wristwatch